By Brooklyn White ·September 20, 2021 Updated
There is hope for a COVID-19 vaccine for young children as they head back to school.
According to study results released this morning, Pfizer and BioNTech have announced positive results following COVID-19 vaccine trials in children aged 5-11. The vaccine was “safe, well tolerated and showed robust neutralizing antibody responses” and administered in two doses, 21 days apart.
The doses were rather low, as 10μg (micrograms) are only
